Below you will find the latest press releases from Evolva. You are also welcome to dive into the archive and browse our press releases from there as well:
Latest Press Releases
Reinach, Switzerland, 5 March 2014 - Evolva Holding SA (SIX: EVE, “Evolva” or the “Company”) announces that Credit Suisse, who is acting as Sole Bookrunner in the private placement announced on 25 February 2014, has exercised in full the over-allotment option of 4,050,000 shares at the placement price of CHF 1.37 per share.
Reinach, Switzerland, 4 March 2014 – Evolva Holding SA (SIX: EVE) today announces that Roquette Frères SA (Roquette) has confirmed that Evolva has achieved the second R&D milestone in their collaboration.
Reinach, Switzerland, 26 February 2014 - Evolva Holding SA (SIX: EVE, “Evolva” or the “Company”) has successfully completed its placement of shares which was announced yesterday. Evolva has sold 27,000,000 new shares via an accelerated bookbuild process
Reinach, Switzerland, 25 February 2014 - Evolva Holding SA reports preliminary, unaudited financial results for 2013 and announces launch of share placement
Reinach, Switzerland, 10 February 2014 - Evolva Holding SA (SIX: EVE) announced that it has signed a collaboration agreement with L’Oréal for the co-development of novel biosynthetic production routes for an undisclosed ingredient with broad applications in the cosmetics industry.
Reinach, Switzerland, 9 January 2014 – Evolva Holding SA (SIX:EVE) has appointed BNY Mellon, the global leader in investment management and investment services, to set up a Level-1 American Depositary Receipt (ADR) programme.